Admilton Gonçalves de Oliveira

Dr. Admilton Gonçalves de Oliveira

Londrina State University, Londrina, Paraná, Brazil
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
AAAmanda Pereira da Costa Araújo
Amanda Pereira da Costa Araújo
NMNathalie Ferreira Silva de Melo
Nathalie Ferreira Silva de Melo
Admilton Gonçalves de OliveiraAdmilton Gonçalves de Oliveira
Admilton Gonçalves de Oliveira
FRFernando Postalli Rodrigues
Fernando Postalli Rodrigues
TFThiago Fernandes
Thiago Fernandes
Guilherme MalafaiaGuilherme Malafaia
Guilherme Malafaia

1 February 2019 in International Journal of Food Microbiology
Verified
Journal Article
Closed access
KBKarla Paiva Bocate
Karla Paiva Bocate
GRGuilherme Fonseca Reis
Guilherme Fonseca Reis
PSPatricia Canteri de Souza
Patricia Canteri de Souza
Admilton Gonçalves de OliveiraAdmilton Gonçalves de Oliveira
Admilton Gonçalves de Oliveira
NDNelson Durán
Nelson Durán
LPLuciano Aparecido Panagio
Luciano Aparecido Panagio

23 May 2016 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
SSSara Scandorieiro
Sara Scandorieiro
LCLarissa C. de Camargo
Larissa C. de Camargo
CLCesar A. C. Lancheros
Cesar A. C. Lancheros
SYSueli F. Yamada-Ogatta
Sueli F. Yamada-Ogatta
CNCelso V. Nakamura
Celso V. Nakamura
RKRenata Kobayashi
Renata Kobayashi
Bacterial resistance to conventional antibiotics has become a clinical and public health problem, making therapeutic decisions more challenging. Plant compounds and nanodrugs have been proposed as potential antimicrobial alternatives. Studies have shown that oregano (Origanum vulgare) essential oil (OEO) and silver nanoparticles have potent antibacterial activity, also against multidrug-resistant strains; however, the strong organoleptic characteristics of OEO and the development of resistance to these metal nanoparticles can limit their use. This study evaluated the antibacterial effect of a two-drug combination of biologically synthesized silver nanoparticles (bio-AgNP), produced by Fusarium oxysporum, and OEO against Gram-positive and Gram-negative bacteria, including multidrug-resistant strains. OEO and bio-AgNP showed bactericidal effects against all seventeen strains tested, with minimal inhibitory concentrations (MIC) ranging from 0.298 to 1.193 mg/mL and 62.5 to 250 µM, respectively. Time-kill curves indicated that OEO acted rapidly (within 10 min), while the metallic nanoparticles took 4 h to kill Gram-negative bacteria and 24 h to kill Gram-positive bacteria. The combination of the two compounds resulted in a synergistic or additive effect, reducing their MIC values and reducing the time of action compared to bio-AgNP used alone, i.e., 20 min for Gram-negative bacteria and 7 h for Gram-positive bacteria. Scanning electron microscopy (SEM) revealed similar morphological alterations in Staphylococcus aureus (non-methicillin-resistant S. aureus, non-MRSA) cells exposed to three different treatments (OEO, bio-AgNP and combination of the two), which appeared cell surface blebbing. Individual and combined treatments showed reduction in cell density and decrease in exopolysaccharide matrix compared to untreated bacterial cells. It indicated that this composition have an antimicrobial activity against S. aureus by disrupting cells. Both compounds showed very low hemolytic activity, especially at MIC levels. This study describes for the first time the synergistic and additive interaction between OEO and bio-AgNP produced by F. oxysporum against multidrug-resistant bacteria, such as MRSA, and β-lactamase- and carbapenemase-producing Escherichia coli and Acinetobacter baumannii strains. These results indicated that this combination can be an alternative in the control of infections with few or no treatment options.

25 May 2016 in Frontiers in Microbiology
Verified
Journal Article
Open access
MCMARTHA VIVIANA TORRES CELY
MARTHA VIVIANA TORRES CELY
Admilton Gonçalves de OliveiraAdmilton Gonçalves de Oliveira
Admilton Gonçalves de Oliveira
VFVanessa F. de Freitas
Vanessa F. de Freitas
MLMarcelo B. de Luca
Marcelo B. de Luca
ABAndré R. Barazetti
André R. Barazetti
GAGaldino Andrade
Galdino Andrade
Nutrient availability is an important factor in crop production, and regular addition of chemical fertilizers is the most common practice to improve yield in agrosystems for intensive crop production. The use of some groups of microorganisms that have specific activity providing nutrients to plants is a good alternative, and arbuscular mycorrhizal fungi (AMF) enhance plant nutrition by providing especially phosphorus (P), improving plant growth and increasing crop production. Unfortunately, the use of AMF as an inoculant on a large scale is not yet widely used, because of several limitations in obtaining a large amount of inoculum due to several factors, such as low growth, the few species domesticated under in vitro conditions, and high competition with native AMF. The objective of this work was to test the infectivity of a Rhizophagus clarus inoculum and its effectiveness as an alternative for P supply in soybean (Glycine max L.) and cotton (Gossypium hirsutum L.). The experiments were carried out in plots and the treatments were: Fertilizer; AMF, AMF + Fertilizer and AMF + ½ Fertilizer; non-inoculated and non-fertilized plants were considered the control. The parameters evaluated were AMF root colonization and effect of inoculation on plant growth and yield under a field conditions. The results showed that AMF inoculation increased the effect of fertilizer application in soybean, and that in cotton R. clarus was more effective than chemical fertilizer

1 December 2019 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
Khamis YoussefKhamis Youssef
Khamis Youssef
Admilton Gonçalves de OliveiraAdmilton Gonçalves de Oliveira
Admilton Gonçalves de Oliveira
CTCesar Augusto Tischer
Cesar Augusto Tischer
IHIbrar Hussain
Ibrar Hussain
Sergio RobertoSergio Roberto
Sergio Roberto

1 January 2013 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
VCViviane F Cardozo
Viviane F Cardozo
Admilton Gonçalves de OliveiraAdmilton Gonçalves de Oliveira
Admilton Gonçalves de Oliveira
ENErick K Nishio
Erick K Nishio
MPMarcia Regina Eches PERUGINI
Marcia Regina Eches PERUGINI
CACélia Gtj Andrade
Célia Gtj Andrade
GNGerson Nakazato
Gerson Nakazato
Background: The emergence of multidrug-resistant bacteria is a world health problem. Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA) strains, is one of the most important human pathogens associated with hospital and community-acquired infections. The aim of this work was to evaluate the antibacterial activity of a Pseudomonas aeruginosa-derived compound against MRSA strains. Methods: Thirty clinical MRSA strains were isolated, and three standard MRSA strains were evaluated. The extracellular compounds were purified by vacuum liquid chromatography. Evaluation of antibacterial activity was performed by agar diffusion technique, determination of the minimal inhibitory concentration, curve of growth and viability and scanning electron microscopy. Interaction of an extracellular compound with silver nanoparticle was studied to evaluate antibacterial effect. Results: The F3 (ethyl acetate) and F3d (dichloromethane- ethyl acetate) fractions demonstrated antibacterial activity against the MRSA strains. Phenazine-1-carboxamide was identified and purified from the F3d fraction and demonstrated slight antibacterial activity against MRSA, and synergic effect when combined with silver nanoparticles produced by Fusarium oxysporum. Organohalogen compound was purified from this fraction showing high antibacterial effect. Using scanning electron microscopy, we show that the F3d fraction caused morphological changes to the cell wall of the MRSA strains. Conclusions: These results suggest that P. aeruginosa-produced compounds such as phenazines have inhibitory effects against MRSA and may be a good alternative treatment to control infections caused by MRSA.